… aeruginosa is a crucial reservoir of β-lactam resistance determinants. This review … the β-lactamases
identified in clinical isolates of P. aeruginosa, with a particular focus on AmpC-type β-…

… aeruginosa. In our study, a total of 75 clinical isolates of P. aeruginosa were studied.
Nitrocefin tests were performed to detect the …

… In the case of Pseudomonas aeruginosa, carbapenem resistance is mostly mediated by OprD
… VIM-type MBLs are relatively frequent in clinical isolates of P. aeruginosa at our Institution. …

… Pseudomonas aeruginosa is one of the bacterial species most frequently responsible for
nosocomial infection and is … and their extended-spectrum derivatives in clinical isolates of P. …

… It is also not unusual to find a single isolate that expresses multiple βlactamase enzymes, …
beta-lactamase enzymes in clinical isolates of P. aeruginosa. Methodology: A total of 202 …

… a multidrug-resistant Pseudomonas aeruginosa clinical isolate (FI-14/157) cultured from a
patient with a vascular graft infection in Florence, Italy. The isolate belonged in the sequence …

… metallo-β-lactamase 1 (NDM-1) in Pseudomonas aeruginosa. … Pseudomonas
aeruginosa clinical isolates MMA83 and MMA533 were screened for the presence of metallo-β-lactamases…

… Spectrum β-lactamases (ESBL), AmpC β lactamases and Metallo β … βlactamase (ESBL),
Amp C β-lactamase and Metallo βlactamase (MBL) producing Pseudomonas aeruginosa and …

… -β-lactamase activity was detected in a carbapenem-resistant Pseudomonas aeruginosa
clinical isolate (isolate VR-… The metallo-β-lactamase determinant was isolated from a genomic …

… -β-lactamase (MBL) production among 104 clinical isolates of Pseudomonas aeruginosa from
… Thirty-nine (37.50%) of isolates were MBL positive by double-disk synergy test. Results of …